Mim Ari to Opioid-Related Disorders
This is a "connection" page, showing publications Mim Ari has written about Opioid-Related Disorders.
Connection Strength
3.457
-
Availability of Long-Acting Injectable Buprenorphine at Substance Use Treatment Facilities in 2021. JAMA. 2024 02 13; 331(6):524-526.
Score: 0.693
-
Impact of an opioid use disorder consult service on hospitalized trauma patients with opioid use disorder. J Trauma Acute Care Surg. 2023 08 01; 95(2):226-233.
Score: 0.651
-
A Model to Improve Care and Enhance the Physician-Patient Relationship for Hospitalized Patients With Opioid Use Disorder. Acad Med. 2023 06 01; 98(6S):S25-S27.
Score: 0.647
-
Improving the management of chronic pain, opioid use, and opioid use disorder in older adults: study protocol for I-COPE study. Trials. 2022 Jul 27; 23(1):602.
Score: 0.623
-
National Coverage of Adolescent Opioid Overdose Prevention Content in Pediatrics Clerkships. J Adolesc Health. 2025 Jun; 76(6):1117-1121.
Score: 0.188
-
A substance use disorder training curriculum for internal medicine residents using resident-empaneled patients. BMC Med Educ. 2024 Apr 30; 24(1):478.
Score: 0.176
-
Low dose IV buprenorphine inductions for patients with opioid use disorder and concurrent pain: a retrospective case series. Addict Sci Clin Pract. 2023 06 01; 18(1):38.
Score: 0.165
-
Targeted virtual opioid overdose education and naloxone distribution in overdose hotspots for older adults during COVID-19. J Am Geriatr Soc. 2022 11; 70(11):E26-E29.
Score: 0.158
-
Overcoming challenges in acute care hospitalizations for patients with opioid use disorder. J Am Pharm Assoc (2003). 2023 Jan-Feb; 63(1):204-211.e2.
Score: 0.156